首页|期刊导航|中国中西医结合杂志|荣筋拈痛方抑制PARP1延缓软骨细胞衰老治疗膝骨关节炎

荣筋拈痛方抑制PARP1延缓软骨细胞衰老治疗膝骨关节炎OA

Rongjin Niantong Formula Alleviates Knee Osteoarthritis by Attenuating Chondrocyte Senescence via Inhibiting PARP1

中文摘要英文摘要

目的 探讨荣筋拈痛方通过多聚ADP核糖聚合酶1(PARP1)延缓软骨细胞衰老治疗膝骨关节炎的作用机制.方法 本研究分为两个实验,实验一将软骨细胞分为si-NC组(阴性对照病毒)、si-PARP1 组(PARP1 敲低)、D-半乳糖(D-gal)+si-NC 组(阴性对照病毒+D-gal)、D-gal+si-PARP1组(PARP1敲低+D-gal).实验二将软骨细胞分为正常组(10%空白血清)、模型组(10%空白血清+10 g/L D-gal)、治疗组(10%荣筋拈痛方含药血清+10 g/L D-gal)、抑制剂组(10%空白血清+10 g/L D-gal+10 μmol/L PJ34).β-半乳糖苷酶染色检测衰老相关β-半乳糖苷酶(SA-β-gal)活性水平;检测烟酰胺腺嘌呤二核苷酸(NAD+)水平及NAD+/还原型辅酶Ⅰ(NADH);EdU法检测细胞增殖水平;ELISA法检测白细胞介素-6(IL-6)、高迁移率族蛋白B1(HMGB1)和肿瘤坏死因子-α(TNF-α)细胞因子含量;Real-time PCR和Western Blot检测PARP1、聚腺苷二磷酸核糖(PAR)、细胞周期蛋白依赖性激酶抑制剂2A(p16)和基质金属蛋白酶13(MMP-13)基因与蛋白表达.结果 实验一结果:与si-NC组比较,D-gal+si-NC 组中 SA-β-gal 阳性率、IL-6、HMGB1、TNF-α 表达及 PARP1、p16、MMP-13 mRNA与蛋白表达升高(P<0.01),NAD+的含量与NAD+/NADH比值、EdU阳性率降低(P<0.05,P<0.01);与 D-gal+si-NC 组比较,D-gal+si-PARP1 组中 SA-β-gal 阳性率、IL-6、HMGB1、TNF-α 表达、PARP1、p16、MMP-13 mRNA 与蛋白表达降低(P<0.05,P<0.01),NAD+的含量与 NAD+/NADH 比值、EdU阳性率升高(P<0.05,P<0.01).实验二结果:与模型组比较,治疗组和抑制剂组中SA-β-gal阳性率、IL-6、HMGB1、TNF-α 表达降低(P<0.05,P<0.01),NAD+的含量与 NAD+/NADH 比值、EdU 阳性率升高(P<0.05,P<0.01),治疗组中 PARP1、p16、MMP-13 及抑制剂组中 p16、MMP-13 mRNA表达降低(P<0.05),治疗组PARP1、PAR、p16、MMP-13及抑制剂组PAR、p16、MMP-13蛋白表达降低(P<0.01).结论 荣筋拈痛方可抑制PARP1表达,降低软骨细胞SA-β-gal阳性率,减少软骨细胞NAD+消耗,促进软骨细胞增殖,下调IL-6、HMGB1、TNF-α细胞因子及PARP1、p16、MMP-13 mRNA及蛋白表达,延缓软骨细胞衰老.

Objective To investigate the mechanism of Rongjin Niantong Formula(RJNTF)in treating knee osteoarthritis(KOA)via in delaying chondrocyte senescence through the modulation of Poly(ADP-ribose)polymerase 1(PARP1).Methods This study was divided into two experiments.In experiment one,chondrocytes were divided into the si-NC group(negative control virus),the si-PARP1 group(PARP1 knockdown),the D-galactose(D-gal)+si-NC group(negative control virus+D-gal)and the D-gal+si-PARP1 group(PARP1 knockdown+D-gal).In experiment two,chondrocytes were divided into the normal group(10%blank serum),the model group(10%blank serum+10 g/L D-gal),the treatment group(10%RJNTF drug-containing serum+10 g/L D-gal)and the inhibitor group(10%blank serum+10 g/L D-gal+10 μmol/L PJ34).Senescence was assessed by senescence-associated β-galactosidase(SA-β-gal staining),and cell proliferation was evaluated by the EdU assay.NAD+levels and the NAD+/nicotinamide adenine dinucleotide(NADH)ratio were measured.Interleukin-6(IL-6),high mobility group box 1(HMGB1),tumor necrosis factor-alpha(TNF-α)were quantified by ELISA.The mRNA and protein expression of Poly ADP-ribose 1(PARP1),multiple tumor suppressor 1(p16)and matrix metallopeptidase 13(MMP-13)were detected by RT-qPCR and Western Blot,respectively.Results Results of experiment 1:Compared with the si-NC group,the positive rate of SA-β-gal,the expressions of IL-6,HMGB1,TNF-α,and the mRNA and protein expressions of PARP1,p16,and MMP-13 in the D-gal+si-NC group increased(P<0.01).The content of NAD+,the ratio of NAD+/NADH,and the positive rate of EdU decreased(P<0.05,P<0.01).Compared with the D-gal+si-NC group,the positive rate of SA-β-gal,the expressions of IL-6,HMGB1,TNF-α,and the mRNA and protein expressions of PARP1,p16,and MMP-13 in the D-gal+si-PARP1 group decreased(P<0.05,P<0.01).The content of NAD+,the ratio of NAD+/NADH,and the positive rate of EdU increased(P<0.05,P<0.01).Results of experiment 2:Compared with the model group,the positive rate of SA-β-gal,the expressions of IL-6,HMGB1,and TNF-α in the treatment group and the inhibitor group decreased(P<0.05,P<0.01),while the content of NAD+,the ratio of NAD+/NADH,and the positive rate of EdU increased(P<0.05,P<0.01).The mRNA expressions of PARP1,p16,MMP-13 in the treatment group and p16,MMP-13 in the inhibitor group decreased(P<0.05),and the protein expressions of PARP1,PAR,p16,MMP-13 in the treatment group and PAR,p16,MMP-13 in the inhibitor group decreased(P<0.01).Conclusions RJNTF ameliorates chondrocyte senescence in KOA by inhibiting PARP1 expression,reducing the positive rate of SA-β-gal in chondrocytes,decreasing the consumption of NAD+in chondrocytes,promoting the proliferation of chondrocytes,down-regulating the expression of IL-6,HMGB1 and TNF-αcytokines and mRNA and protein expression of PARP1,p16 and MMP-13.

李璐;郑若曦;戴雨婷;王如意;陈楠;陈俊;吴广文

福建中医药大学中医骨伤及运动康复教育部重点实验室(福州 350122)福建中医药大学中医骨伤及运动康复教育部重点实验室(福州 350122)福建中医药大学骨伤学院(福州 350122)福建中医药大学中医骨伤及运动康复教育部重点实验室(福州 350122)福建中医药大学骨伤学院(福州 350122)福建中医药大学中医骨伤及运动康复教育部重点实验室(福州 350122)福建中医药大学中医骨伤及运动康复教育部重点实验室(福州 350122)

荣筋拈痛方膝骨关节炎软骨细胞衰老多聚ADP核糖聚合酶1中药复方

Rongjin Niantong Formulaknee osteoarthritischondrocyte senescencePARP1Chinese herbal compound

《中国中西医结合杂志》 2026 (1)

67-74,8

国家自然科学基金资助项目(No.82405443,No.82474553)

10.7661/j.cjim.20251122.226

评论